Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioavailability of a Formulation of Diosmin/Hesperidin (90/10) 500 mg Tablets With Regards to the Marketed Reference Product

NCT05158192 is registered in ClinicalTrials.gov with Laboratorios Andromaco S.A. as lead sponsor.

NCT NCT05158192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05158192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioavailability of a Formulation of Diosmin/Hesperidin (90/10) 500 mg Tablets With Regards to the Marketed Reference Product
Lead sponsor
Laboratorios Andromaco S.A.
Phase
Phase 1
Overall status
Completed
Start date
November 4, 2021
Completion date
December 14, 2021
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bioequivalence